Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2021-04-16
Product name
GW572016F 250 MG TABLETS * LAPATINIB DITOSYLATE MONOHYDRATE, FORMULATED
Product Synonyms
GW572016F 250 MG TABLETS * LAPATINIB DITOSYLATE MONOHYDRATE, FORMULATED
CAS No.
9004-34-6
1.2.1 Relevant identified uses
Bulk Formulated Product
1.2.2. Uses advised against
No other uses are advised
Icons in SDS
Company Information
company name
GlaxoSmithKline Singapore Pharmaceuticals
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
None
Section 2
Physical hazards
Not classified.
Health hazards
Not classified.
Environmental hazards
Not classified.
Hazard pictograms
None.
Signal word
None.
Hazard statements
The mixture does not meet the criteria for classification.
Prevention
Not available.
Response
Not available.
Storage
Not available.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations.
Other hazards which do not result in classification
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
Additional information
41.7 % of the mixture consists of component(s) of unknown acute oral toxicity. 97.1 % of the mixture consists of component(s) of unknown acute dermal toxicity. 53.4 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 53.4 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.